期刊文献+

胃癌患者外周血调节性T细胞密度的临床意义及预后价值研究 被引量:2

Clinical and prognostic significance of regulatory T cell density in peripheral blood of patients with gastric carcinoma
下载PDF
导出
摘要 目的 了解胃癌患者外周血调节性T细胞(Treg)密度与患者临床病理特征及术后预后的关系.方法 使用流式细胞计数法测定一组接受根治性手术的胃癌患者(n=75)及健康对照组(n=25)外周血中CD4+ CD25+ FoxP3+的Treg密度,比较两组患者Treg的平均水平,并分析Treg密度与胃癌患者的临床病理特征及预后的关系.结果 胃癌患者外周血Treg平均密度显著高于对照组(P =0.007).与Treg低密度的患者相比,高密度的患者肿瘤平均直径较大(P=0.013)、TNM分期更高(P =0.029),其术后复发率较高(P =0.029)、生存时间较短(P =0.025).结论 胃癌患者外周血Treg密度显著增加,且提示预后不佳. Objective To investigate the relationships among the peripheral blood regulatory T (Treg) cell density,clinicopathological features and post-operative prognosis in patients with gastric carcinoma.Methods The density of CD4 + CD25 + FoxP3 + Treg cell was prospectively calculated with flow cytometer in the peripheral blood from a series of patients with gastric carcinoma(n =75)and healthy controls(n =25).The mean numbers of Treg cell were compared between the two groups.In patients with gastric carcinoma,associations among Treg density,clinicopathological features and post-operative prognosis were analyzed.Results The average level of Treg density in patients was significandy higher than that in healthy controls(P =0.007).Gastric carcinoma patients with high Treg densities had larger tumor sizes (P =0.013),more advanced TNM stages (P =0.029),higher rates of tumor recurrence (P =0.029) and shorter overall survivals(P =0.025).Conclusion The density of Treg cell elevated in patients with gastric carcinoma,and high Treg density is an indicator of poor prognosis.
作者 吴建武
出处 《临床外科杂志》 2014年第7期517-519,共3页 Journal of Clinical Surgery
关键词 调节性T细胞 胃癌 肿瘤分期 预后 regulatory T cell gastric carcinoma tumor stage prognosis
  • 相关文献

参考文献12

  • 1马桂芬,陈世耀.叉头样转录因子3与胃癌的研究进展[J].复旦学报(医学版),2011,38(3):271-274. 被引量:2
  • 2Raghavan S, Quiding-Jarbrink M. Regulatory T cells in gastrointestinal tumors[ J]. Expert Rev Gastroenterol Hepato1,2011,5 (4) :489-501.
  • 3沈琳.胃癌诊疗规范(2011年版)[M].北京:人民卫生出版社,2011:1.
  • 4于益芝,曹雪涛.调节性T细胞在肿瘤免疫和肿瘤免疫治疗中的作用[J].中国肿瘤生物治疗杂志,2010,17(1):1-6. 被引量:51
  • 5Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients [ J 1. Clin Cancer Res, 2003,9 ( 2 ) : 606-612.
  • 6Gabitass RF,Annels NE, Stocken DD, et al. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an in- dependent prognostic factor and are associated with significant eleva- tion of the Th2 cytokine interleukin-13 [J]. Cancer immunol immu- nother,2011,60(10) :1419-1430.
  • 7Raghavan S, Quiding-Jarbrink M. Regulatory T cells in gastrointestinal tumors [ J ]. Expert Rev Gastroenterol Hepato1,2011,5 (4) :489-501.
  • 8Nishikawa H, Sakaguchi S. Regulatory T cells in cancer immunothera- py [ J ]. Current opinion in immunology ,2014,27C : 1-7.
  • 9Shen Z, Zhou S, Wang Y, et al. Higher intratumoral infiltrated Foxp3 Treg numbers and Foxp3 /CD8 ratio are associated with adverse prognosis in resectable gastric cancer[ J]. J Cancer Res Clin Oncol, 2010,136(10) :1585-1595.
  • 10Lu X, Liu J, Li H, et al. Conversion of intratumoral regulatory T ceils by human gastric cancer cells is dependent on transforming growth fac- tor-betal[ J]. J Surg Onco1,2011,104 (6) :571-577.

二级参考文献95

  • 1Gershon RK, Kondo K. Infectious immunological tolerance [J]. Immunology, 1971 , 21 (6) : 903-914.
  • 2Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes [ J ]. Immunology, 1970, 18 ( 5 ) : 723-737.
  • 3Fujimoto S, Greene M, Sehon AH. Immunosuppressor T cells in tumor bearing host [J]. Immunol Commun, 1975, 4(3):201- 217.
  • 4Berendt MJ, North RJ. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenie tumor [J]. J Exp Med, 1980, 151 ( 1 ) : 69-80.
  • 5Bursuker I, North RJ. Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity [J]. J Exp Med, 1984, 159(5) : 1312-1321.
  • 6North R J, Bursuker I. Generation and decay of the immune response to a progressive fibrosarcoma. I Ly-1-2- suppressor T ceils down-regulate the generation of Ly-1-2 + effector T cells [ J 1. J Exp Med, 1984, 159(5) : 1295-1311.
  • 7Chakraborty NG, Twardzik DR, Sivanandham M, Ergin MT, Hellstrom KE, Mukherji B. Autologous melanoma-induced activation of regulatory T ceils that suppress cytotoxic response [ J ]. J Immunol, 1990, 145(7) : 2359-2364.
  • 8Sakaguchi S, Sakaguehi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains ( CD25 ). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases [ J]. J Immunol, 1995, 155(3): 1151-1164.
  • 9Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 ( interleukin-2 receptor alpha) monoclonal antibody [ J ]. Cancer Res, 1999, 59(13): 3128-3133.
  • 10Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25 + CD4 + T cells : a common basis between tumor immunity and autoimmunity [ J]. J Immunol, 1999, 163 (10): 5211-5218.

共引文献52

同被引文献21

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部